Significant Wealth Partners LLC Grows Position in Humana Inc. (NYSE:HUM)

Significant Wealth Partners LLC raised its holdings in shares of Humana Inc. (NYSE:HUM) by 56.7% during the first quarter, according to its most recent filing with the SEC. The firm owned 848 shares of the insurance provider’s stock after purchasing an additional 307 shares during the period. Significant Wealth Partners LLC’s holdings in Humana were worth $294,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of HUM. Exchange Traded Concepts LLC boosted its holdings in shares of Humana by 2.3% in the 4th quarter. Exchange Traded Concepts LLC now owns 2,950 shares of the insurance provider’s stock valued at $1,351,000 after buying an additional 67 shares in the last quarter. Baldwin Brothers LLC MA lifted its position in Humana by 1.6% during the fourth quarter. Baldwin Brothers LLC MA now owns 40,646 shares of the insurance provider’s stock valued at $18,608,000 after acquiring an additional 630 shares during the last quarter. First Hawaiian Bank boosted its stake in Humana by 10.9% in the fourth quarter. First Hawaiian Bank now owns 2,931 shares of the insurance provider’s stock valued at $1,342,000 after acquiring an additional 289 shares in the last quarter. Central Bank & Trust Co. grew its holdings in Humana by 7.7% in the fourth quarter. Central Bank & Trust Co. now owns 3,983 shares of the insurance provider’s stock worth $1,823,000 after purchasing an additional 284 shares during the last quarter. Finally, Walker Financial Services Inc. increased its position in shares of Humana by 3.9% during the fourth quarter. Walker Financial Services Inc. now owns 795 shares of the insurance provider’s stock worth $364,000 after purchasing an additional 30 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on HUM shares. UBS Group lowered their price objective on Humana from $334.00 to $326.00 and set a “neutral” rating for the company in a research report on Thursday, April 25th. Bank of America boosted their price target on Humana from $342.00 to $376.00 and gave the stock a “neutral” rating in a research note on Monday, May 20th. Royal Bank of Canada decreased their price objective on shares of Humana from $415.00 to $353.00 and set an “outperform” rating for the company in a research report on Thursday, April 25th. Oppenheimer dropped their target price on shares of Humana from $415.00 to $370.00 and set an “outperform” rating on the stock in a research report on Thursday, April 25th. Finally, Truist Financial raised their price target on shares of Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a report on Monday. Fourteen investment analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $402.05.

Humana Stock Performance

Shares of HUM traded up $7.77 during trading hours on Monday, hitting $389.99. The stock had a trading volume of 906,797 shares, compared to its average volume of 1,766,184. The firm has a 50-day moving average price of $355.39 and a 200 day moving average price of $346.45. Humana Inc. has a fifty-two week low of $298.61 and a fifty-two week high of $530.54. The firm has a market capitalization of $46.99 billion, a price-to-earnings ratio of 24.26, a PEG ratio of 2.21 and a beta of 0.51. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.67 and a current ratio of 1.67.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, beating analysts’ consensus estimates of $6.12 by $1.11. Humana had a net margin of 1.82% and a return on equity of 17.76%. The company had revenue of $29.61 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter in the previous year, the company earned $9.38 earnings per share. The firm’s revenue for the quarter was up 10.7% on a year-over-year basis. As a group, research analysts anticipate that Humana Inc. will post 16.27 EPS for the current year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 0.91%. The ex-dividend date of this dividend is Friday, June 28th. Humana’s payout ratio is 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.